Post-approval studies seldom cover the deficit of knowledge about orphan drugs, find Roberta Joppi and colleagues
No takes yet. Share an insight, caveat, or question.
Joppi et al. (2016) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: